Researchers develop an effective strategy against KRAS mutant lung tumors in mice
The KRAS oncogene is involved in at least one fifth of all human cancers: KRAS mutations are directly responsible for 32% of lung tumors and 96% of pancreatic tumors. However, after more than thirty years of research to date, there are still no effective therapeutic strategies against this oncogene. For this reason, much of the […]
Continue Reading